Sildigra 100 mg is a generic medication used to treat erectile dysfunction (ED) in men. Generic medications are typically more affordable than brand-name medications for several reasons:

No Research and Development Costs: Brand-name medications undergo extensive research and development (R&D) to bring them to market, which can be costly. Generic medications, on the other hand, do not require this investment because they are copies of existing brand-name drugs whose patents have expired. This absence of R&D costs allows generic manufacturers to produce the medication at a lower cost.
Competition: Once the patent for a brand-name medication expires, other manufacturers can produce generic versions of the drug. Increased competition among generic manufacturers can drive down prices as companies vie for market share.
Lower Marketing Costs: Brand-name medications often incur significant marketing expenses to promote their products. Generic manufacturers typically spend less on marketing because they do not need to establish brand recognition or advertise directly to consumers.
Regulatory Pathway: Generic medications follow a different regulatory pathway than brand-name drugs. Generic manufacturers are not required to conduct clinical trials to prove safety and efficacy; instead, they must demonstrate bioequivalence to the brand-name drug. This streamlined regulatory process reduces the time and cost of bringing generic medications to market.
No Patent Protection: Brand-name medications are protected by patents, which grant exclusive rights to the manufacturer for a certain period, typically 20 years. Once the patent expires, other companies can produce generic versions of the drug, leading to increased competition and lower prices.
Overall, the lower cost of generic medications like Sildigra 100 mg can make them more accessible and affordable for consumers, while still providing the same active ingredients and therapeutic effects as their brand-name counterparts.